SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-114948
Filing Date
2020-10-14
Accepted
2020-10-14 16:57:06
Documents
54
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029669-1_10q.htm 10-Q 468256
2 EXHIBIT 31.1 tm2029669d1_ex31-1.htm EX-31.1 10975
3 EXHIBIT 32.1 tm2029669d1_ex32-1.htm EX-32.1 4576
  Complete submission text file 0001104659-20-114948.txt   4260676

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20200831.xml EX-101.INS 1015032
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20200831.xsd EX-101.SCH 40832
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20200831_cal.xml EX-101.CAL 35898
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20200831_def.xml EX-101.DEF 177087
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20200831_lab.xml EX-101.LAB 349382
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20200831_pre.xml EX-101.PRE 282237
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 201239498
SIC: 2834 Pharmaceutical Preparations